Company Analysis Tenaya Therapeutics, Inc.
1. Summary
Advantages
- Price (0.6296 $) is less than fair price (2.69 $)
Disadvantages
- Dividends (0%) are below the sector average (0.5431%).
- The stock's return over the last year (-88.95%) is lower than the sector average (-5.51%).
- Current debt level 11.35% has increased over 5 years from 0%.
- The company's current efficiency (ROE=-95.69%) is lower than the sector average (ROE=6.54%)
Similar companies
2. Share price and performance
2.1. Share price
2.2. News
2.3. Market efficiency
| Tenaya Therapeutics, Inc. | Healthcare | Index | |
|---|---|---|---|
| 7 days | -1.2% | -36.7% | 4% |
| 90 days | -66.2% | -12.6% | -15% |
| 1 year | -88.9% | -5.5% | 8.1% |
TNYA vs Sector: Tenaya Therapeutics, Inc. has significantly underperformed the "Healthcare" sector by -83.44% over the past year.
TNYA vs Market: Tenaya Therapeutics, Inc. has significantly underperformed the market by -97.05% over the past year.
Slightly volatile price: TNYA is more volatile than the rest of the market on "NASDAQ" over the last 3 months, with typical deviations of about +/- 5-15% per week.
Long period: TNYA with weekly volatility of -1.71% over the past year.
3. Summary of the report
4. Fundamental Analysis
4.1. Stock price and price forecast
Below fair price: The current price (0.6296 $) is lower than the fair price (2.69 $).
Price significantly below the fair price: The current price (0.6296 $) is 327.3% lower than the fair price.
4.2. P/E
P/E vs Sector: The company's P/E (0) is lower than that of the sector as a whole (64.63).
P/E vs Market: The company's P/E (0) is lower than that of the market as a whole (93.32).
4.2.1 P/E Similar companies
4.3. P/BV
P/BV vs Sector: The company's P/BV (1.31) is lower than that of the sector as a whole (4.52).
P/BV vs Market: The company's P/BV (1.31) is lower than that of the market as a whole (5.61).
4.3.1 P/BV Similar companies
4.4. P/S
P/S vs Sector: The company's P/S indicator (0) is lower than that of the sector as a whole (33.51).
P/S vs Market: The company's P/S indicator (0) is lower than that of the market as a whole (10.28).
4.4.1 P/S Similar companies
4.5. EV/Ebitda
EV/Ebitda vs Sector: The company's EV/Ebitda (-1.13) is higher than that of the sector as a whole (-19.11).
EV/Ebitda vs Market: The company's EV/Ebitda (-1.13) is lower than that of the market as a whole (19.31).
5. Profitability
5.1. Profitability and revenue
5.2. Earnings per share - EPS
5.3. Past profitability Net Income
Yield Trend: Rising and has grown by 38.49% over the last 5 years.
Earnings Slowdown: The last year's return (0%) is below the 5-year average return (38.49%).
Profitability vs Sector: The return for the last year (0%) exceeds the return for the sector (-26.26%).
5.4. ROE
ROE vs Sector: The company's ROE (-95.69%) is lower than that of the sector as a whole (6.54%).
ROE vs Market: The company's ROE (-95.69%) is lower than that of the market as a whole (5.31%).
5.5. ROA
ROA vs Sector: The company's ROA (-76.52%) is lower than that of the sector as a whole (-0.7601%).
ROA vs Market: The company's ROA (-76.52%) is lower than that of the market as a whole (6.12%).
5.6. ROIC
ROIC vs Sector: The company's ROIC (-101.51%) is lower than that of the sector as a whole (7.63%).
ROIC vs Market: The company's ROIC (-101.51%) is lower than that of the market as a whole (10.94%).
7. Dividends
7.1. Dividend yield vs Market
Low yield: The dividend yield of the company 0% is below the average for the sector '0.5431%.
7.2. Stability and increase in payments
Unstable dividends: The company's dividend yield 0% has not been consistently paid over the past 7 years, DSI=0.
Weak dividend growth: The company's dividend yield 0% has been growing weakly or stagnant over the past 5 years. Growth over only 0 years.
7.3. Payout percentage
Dividend Coverage: Current payments from income (0%) are at an uncomfortable level.
Pay for your subscription
More functionality and data for company and portfolio analysis is available by subscription
